Orthopedia Stock Price, News & Analysis

OrthoPediatrics Corp. (Nasdaq: KIDS) announced its Platinum-level sponsorship for the AACPDM Annual Meeting, occurring virtually from October 6-9, 2021. The company will provide scholarships, educational support, and showcase products at the event. OrthoPediatrics emphasizes its commitment to pediatric orthopedic education, having recently participated in the Scoliosis Research Society meeting and the POST Course, which trains orthopedic residents in pediatric surgical techniques. President David Bailey highlighted the positive impact of their educational support in advancing the field.

OrthoPediatrics Corp. (Nasdaq: KIDS) has announced a 5-year exclusive distribution agreement with SeaSpine Orthopedics to distribute the 7D Surgical FLASH™ Navigation platform for pediatric applications. This agreement allows OrthoPediatrics to enhance surgical workflows and patient safety in pediatric orthopedic surgeries by utilizing radiation-free technology. The FLASH Navigation system, featuring innovative camera-based technology, eliminates the need for intra-operative CT and fluoroscopy, significantly reducing radiation exposure. This partnership aligns with OrthoPediatrics' commitment to pediatric orthopedics and innovation.

OrthoPediatrics Corp. (Nasdaq: KIDS) reported a 96% revenue increase for Q2 2021, reaching $26.7 million compared to $13.6 million in Q2 2020. U.S. revenue rose 79% to $21.7 million, while international revenue surged 243% to $5.0 million. Key drivers included substantial growth in Trauma & Deformity (up 95%), Scoliosis (up 100%), and Sports Medicine (up 106%). Gross profit improved by 103% to $20.4 million, with a profit margin of 76.6%. The company increased its full-year revenue guidance to $97-$101 million, indicating strong momentum despite potential COVID-19 challenges.

OrthoPediatrics Corp. (Nasdaq: KIDS) announces a five-year extension of its partnership with Mighty Oak Medical, prolonging their exclusive distribution of FIREFLY Technology until August 2027. This collaboration has enhanced pediatric surgical outcomes by providing 3D printed, patient-specific navigation guides that minimize intraoperative radiation. The partnership underscores a shared commitment to improving the lives of children facing orthopedic challenges.

OrthoPediatrics Corp. (Nasdaq: KIDS) announced its Diamond sponsorship for the 31^st Annual Baltimore Limb Deformity Course, returning to a live format after a virtual event in 2020. The event will take place from August 4 to 8 in Baltimore, Maryland, where the company will offer registration scholarships to residents and fellows. OrthoPediatrics will also showcase its External Fixation portfolio through hands-on demonstrations and workshops. Newly appointed CEO David Bailey emphasized the event's significance in pediatric orthopedic education.

OrthoPediatrics Corp. (NASDAQ: KIDS) is set to announce its second quarter 2021 financial results on August 5, 2021, prior to market opening. A conference call will follow at 8:00 a.m. ET, providing insights into the financial performance. Interested parties can join via dial-in numbers or online webcast. OrthoPediatrics, established in 2006, focuses exclusively on pediatric orthopedics, offering 36 surgical systems across major categories such as trauma, scoliosis, and sports medicine. The company distributes globally, affecting pediatric orthopedic care.

OrthoPediatrics Corp. (NASDAQ: KIDS) has launched its 6.5mm/7.3mm Slipped Capital Femoral Epiphysis (SCFE) Cannulated Screw system after receiving FDA 510(k) clearance. This innovative system features fully and partially threaded screws designed specifically for pediatric patients, available in 2mm increments. The addition expands OrthoPediatrics' offerings, which now includes screws in multiple sizes to meet the needs of pediatric orthopedic surgeons. This launch reinforces the company's commitment to advancing pediatric orthopedic care.

OrthoPediatrics Corp (Nasdaq: KIDS) announced participation in the 2021 JMP Securities Life Sciences Conference on June 17, 2021. Key executives, including CEO Dave Bailey, COO and CFO Fred Hite, and Executive Chairman Mark Throdahl, will engage in a fireside chat at 12:00pm ET. An audio webcast of the event will be available on the company's investor relations website, with a replay accessible for 90 days post-event. OrthoPediatrics specializes in pediatric orthopedics, offering 36 surgical systems across trauma, scoliosis, and sports medicine.

OrthoPediatrics Corp. (Nasdaq: KIDS) has completed a leadership transition, appointing David Bailey as the new Chief Executive Officer, succeeding Mark Throdahl, who will remain as Executive Chairman. Throdahl praised Bailey's experience since joining the company in 2007, expressing confidence in his leadership. Bailey emphasized that the company's strategy will remain unchanged, focusing on executing growth plans and delivering innovative products for pediatric orthopedic surgeons to improve children's lives. The company markets 36 surgical systems across key categories in pediatric orthopedics.